
Latest Headlines

February 17, 2025
Primary Analysis of ZUMA-2: Bruton Tyrosine Kinase Inhibitor–Naive Relapsed or Refractory Mantle Cell Lymphoma
The ASCO Post



February 17, 2025
ChatGPT Has Limitations in Clinical Utility for Colorectal Cancer but May Be Useful for Patient Education
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

February 17, 2025
How Telehealth Is Broadening Access to Early Palliative Care and Improving Outcomes for Patients With Advanced Lung Cancer
The ASCO Post

February 17, 2025
BOREAS Trial: Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis
The ASCO Post

February 17, 2025
Experimental Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer
The ASCO Post

February 17, 2025
FDA Approves Preparative Regimen for Allogeneic HSCT in Patients With AML or MDS
The ASCO Post
Advertisement
Recommendations
Advertisement